Bone mass is sensitive to mechanical stresses such that under periods of reduced strain (i.e. spaceflight,bed rest, etc) bone density is reduced, while repetitive load bearing stresses (i.e. physical activity) on theskeleton lead to increased bone formation. The mechanism of this regulation is not clear, but is thought toinvolve mechanosensors that detect shear forces caused by fluid flow through the bone canaliculi inresponse to the compression of the bone. The osteocytes located in the bone matrix are thought to be thecells responsible for detecting this mechanical signal. The osteocyte has an elaborate communicationsystem interconnecting with the osteoblasts that line the bone and mediate mineral deposition and with theosteoclasts that reabsorb bone. Thus, the osteocyte is ideally positioned to sense external stresses andelicit appropriate adaptive responses needed to remodel bone; however, the mechanism by which itmediates this sensory response is unknown.Based on data from ductal epithelium in the kidney, we predict that the mechanical stress placed on theDone will be perceived by a primary cilium located on the osteocyte. As in the kidney, the primary cilia wouldfunction as a mechanosensor detecting flow through deflection of the axoneme. We predict this will result incalcium entry through the cilium requiring the nonselective cation channel polycystin-2. As in the renalepithelium this would lead to the release of internal calcium stores. While the physiological consequence ofthe calcium signal in the kidney is unknown, in the case of bone we predict it will regulate pathwaysgoverning bone formation and reabsorption. It is these possibilities that we want to test in this Pilot andFeasibility study.Thus the goal of this application is to evaluate the importance of the primary cilium and polycystin-2 fornormal bone homeostasis. We will first determine the position of the cilium on the osteocyte in relation to thecanaliculi and evaluate whether the polycystin-2 channel is present on the cilia as seen in the tubules of thekidney. We will then disrupt cilia or polycystin-2 function in the osteocytes/osteoblast. Since congenicmutations that completely disrupt cilia formation or polycystin-2 function are not viable and die before bonedevelopment occurs, we will cross conditional floxed mutant alleles of Tg737 and Kif3a (cilia assemblygenes) and polycystin-2 with transgenic mice expressing Cre recombinase from the osteocalcin (OC::Cre)promoter. We will also use an OC::Cre line where Cre activity will be tamoxifen inducible which will allow usto disrupt cilia/polycystin-2 function during development or in adults. The consequence of the loss of cilia andpolycystin-2 function on bone development and maintenance will be assessed by microCT, DEXA, and byhistomorphometry. Future research directions of this application would involve the isolation of osteocytes toevaluate their ability to respond to fluid flow in presence or absence of cilia and polycystin-2. In addition, wewill assess the effect of cilia) dysfunction on pathways, such as IGF and NO, that are involved in theregulation of bone homeostasis. Overall, these analyses will provide novel insights into the mechanosensoryrole of the primary cilium on the osteocyte and how this cell regulates bone formation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR048311-07
Application #
7669286
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2008-09-01
Project End
2012-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
7
Fiscal Year
2008
Total Cost
$53,702
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Yang, Zhengrong; Hildebrandt, Ellen; Jiang, Fan et al. (2018) Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1. Biochim Biophys Acta Biomembr 1860:1193-1204
Smith, Samuel R; Schaaf, Kaitlyn; Rajabalee, Nusrah et al. (2018) The phosphatase PPM1A controls monocyte-to-macrophage differentiation. Sci Rep 8:902
Chen, Wei; Zhu, Guochun; Jules, Joel et al. (2018) Monocyte-Specific Knockout of C/ebp? Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebp? in Osteoclast Differentiation and Function. J Bone Miner Res 33:691-703
Wang, Yong; Schafer, Cara C; Hough, Kenneth P et al. (2018) Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol 201:278-295
Jones, Robert B; Dorsett, Kaitlyn A; Hjelmeland, Anita B et al. (2018) The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1? signaling. J Biol Chem 293:5659-5667
Bandari, Shyam K; Purushothaman, Anurag; Ramani, Vishnu C et al. (2018) Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 65:104-118
Jo, SeongHo; Chen, Junqin; Xu, Guanlan et al. (2018) miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function. Diabetes 67:256-264
Stafman, Laura L; Williams, Adele P; Garner, Evan F et al. (2018) Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma. Transl Oncol 12:200-208
Hamilton, Jennie A; Wu, Qi; Yang, PingAr et al. (2018) Cutting Edge: Intracellular IFN-? and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells. J Immunol 201:2203-2208
Yang, Zhenhua; Shah, Kushani; Busby, Theodore et al. (2018) Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer. J Clin Invest 128:3605-3618

Showing the most recent 10 out of 340 publications